Schema Therapy
Showing 1 - 25 of >10,000
Borderline Personality Disorder Trial (Individual Schema Therapy (IST), Individual-Group Schema Therapy (IGST))
Not yet recruiting
- Borderline Personality Disorder
- Individual Schema Therapy (IST)
- Individual-Group Schema Therapy (IGST)
- (no location specified)
Aug 10, 2023
Treatment Resistant Depression, Chronic Depression Trial in Denmark (Schema therapy, Other psychotherapy, Standard care package
Not yet recruiting
- Treatment Resistant Depression
- Chronic Depression
- Schema therapy
- +2 more
-
Ballerup, Denmark
- +3 more
Apr 15, 2023
Anorexia Nervosa, Atypical Anorexia Nervosa (Other Specified Eating Disorder), Bulimia Nervosa Trial (GST, CBT-E)
Not yet recruiting
- Anorexia Nervosa
- +3 more
- GST
- CBT-E
- (no location specified)
Apr 13, 2023
Trauma, Psychological, Personality Disorders, Chronic Psychiatric Disorder Trial in Sittard (Schema Therapy and the Healthy
Completed
- Trauma, Psychological
- +2 more
- Schema Therapy and the Healthy Adult
-
Sittard, Limburg, NetherlandsZuyderland MC
Jan 24, 2022
Depressive Symptoms, Anxiety Disorders, Persistent Trial (short-term schema focused group therapy)
Not yet recruiting
- Depressive Symptoms
- +3 more
- short-term schema focused group therapy
- (no location specified)
Jul 13, 2023
Latent Toxoplasmosis in Females With Borderline Personality
Suspended
- Borderline Personality Disorder
- Toxoplasmosis
- Combined schema-therapy and cognitive behavioral therapy
- Psychopharmaceuticals
-
Olomouc, CzechiaDepartment of Psychiatry, Palacky University, University Hospita
Sep 26, 2022
MDD Trial in Munich (schema therapy, cognitive behavioral therapy, individualized supportive therapy)
Active, not recruiting
- Major Depressive Disorder
- schema therapy
- +2 more
-
Munich, GermanyMax Planck Institute of Psychiatry
Mar 22, 2021
Borderline Personality Disorder Trial in Mataro (Treatment as usual (schema therapy), Mobile app)
Recruiting
- Borderline Personality Disorder
- Treatment as usual (schema therapy)
- Mobile app
-
Mataro, Barcelona, SpainConsorci Sanitari del Maresme
Mar 7, 2022
Borderline Personality Disorder, Randomized Controlled Trial Trial (Group Schema therapy, Individual Schema therapy)
Completed
- Borderline Personality Disorder
- Randomized Controlled Trial
- Group Schema therapy
- Individual Schema therapy
- (no location specified)
Dec 23, 2019
Melanoma Trial in France (Nivolumab + Ipilimumab, Combined treatment schema)
Terminated
- Melanoma
- Nivolumab + Ipilimumab
- Combined treatment schema
-
Bordeaux, France
- +5 more
Dec 3, 2020
Anxiety Trial in Paris (schema therapy)
Unknown status
- Anxiety
- schema therapy
-
Paris, Franceuniversity Paris Nanterre
Jul 27, 2019
Cluster C Personality Disorder (Diagnosis), Mother-Child Relations Trial (Group schematherapy)
Not yet recruiting
- Cluster C Personality Disorder (Diagnosis)
- Mother-Child Relations
- Group schematherapy
- (no location specified)
Oct 21, 2023
Cancer Survivors, African Americans, Women Trial (Gratitude Intervention)
Not yet recruiting
- Cancer Survivors
- +7 more
- Gratitude Intervention
- (no location specified)
Aug 17, 2022
Self-Criticism Trial in Groningen (Double Standards, Self-criticism avatar)
Recruiting
- Self-Criticism
- Double Standards
- Self-criticism avatar
-
Groningen, NetherlandsUniversity Medical Center Groningen
Jun 2, 2023
Delving Into Borderline Personality Disorder Clinical Trial
Not yet recruiting
- Borderline Personality Disorder
-
San Francisco, CaliforniaPower Life Sciences
Aug 4, 2023
Bipolar Disorder Trial in Le Chesnay
Recruiting
- Bipolar Disorder
-
Le Chesnay, FrancePaul ROUX
Mar 8, 2022
Validation of Schema Scale of Mental Health Service
Completed
- Mental Health Services
- Personality
- Digital Psychological Test: Schema Scale
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jul 11, 2023
Refractory Myasthenia Gravis, Rituximab Trial in Guangzhou (Rituximab)
Recruiting
- Refractory Myasthenia Gravis
- Rituximab
-
Guangzhou, ChinaFirst Affiliated Hospital, Sun Yat-Sen University
Apr 26, 2022
Glioblastoma Trial in France (Hypofractionated stereotactic radiation therapy, Durvalumab)
Recruiting
- Glioblastoma
- Hypofractionated stereotactic radiation therapy
- Durvalumab
-
Angers, France
- +9 more
Mar 25, 2022
Breast Cancer, Hormone Receptor Positive Tumor Trial in Germany (3 weeks Dose Induction of Everolimus, 3 weeks Conventional
Completed
- Breast Cancer
- Hormone Receptor Positive Tumor
- 3 weeks Dose Induction of Everolimus
- +3 more
-
Neu Isenburg, Hessen, Germany
- +13 more
Feb 22, 2022
Post Traumatic Stress Disorder Trial in Tours (Survey)
Recruiting
- Post Traumatic Stress Disorder
- Survey
-
Tours, FranceUHTours
Jan 31, 2023
Recurrent Prostate Cancer After Surgery Trial in Rochester (Daily-adaptive Stereotactic Body Radiation Therapy)
Not yet recruiting
- Recurrent Prostate Cancer After Surgery
- Daily-adaptive Stereotactic Body Radiation Therapy
-
Rochester, New YorkWilmot Cancer Institute - Dept of Radiation Oncology
Jul 7, 2023
IgA Nephropathy, Immunoglobulin A Nephropathy Trial (Atrasentan, Placebo)
Not yet recruiting
- IgA Nephropathy
- Immunoglobulin A Nephropathy
- Atrasentan
- Placebo
- (no location specified)
Apr 27, 2023
Triple Negative Breast Cancer Metastatic Trial in Milano, Padova (Ceralasertib, Durvalumab, Nab-paclitaxel)
Recruiting
- Triple Negative Breast Cancer Metastatic
- Ceralasertib
- +2 more
-
Milano, Italy
- +1 more
Jan 16, 2023